EPISEEK multi-rákszűrő vérteszt

EPISEEK multi-rákszűrő vérteszt

Brand: Neumann Labs
249900.00 HUF In stock Buy at Merchant

The EPISEEK test screens for over 60 cancer types from a blood sample, aiming to detect cancers early before symptoms appear.

  • The description claims that early detection can save lives.
  • The description claims that the 5-year survival rate for stage I thick bladder cancer is about 91%, compared to about 13% for stage IV.
Variants (1)
  • Default Title — 249900.00 HUF — In stock

AI Readiness

Good foundation, but some important product data is still missing.

76%
3 important fields missing Claim to view full AI report
Data sourced from neumannlabs.co. Last updated: The description was auto-generated by an AI model based on the merchant's description. It may not be accurate or complete.
Claim neumannlabs.co to see AI Product Health

Takes ~2 minutes. No storefront changes.